{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T13:22:04Z","timestamp":1789132924028,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000278","name":"Department for International Development, UK Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill & Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-034281"],"award-info":[{"award-number":["INV-034281"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023693","name":"Vaccine Impact Modelling Consortium","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023693","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/X020258\/1"],"award-info":[{"award-number":["MR\/X020258\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"National Institute for Health Research Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epidemics"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.epidem.2024.100798","type":"journal-article","created":{"date-parts":[[2024,11,6]],"date-time":"2024-11-06T18:20:50Z","timestamp":1730917250000},"page":"100798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Direct and indirect effects of hepatitis B vaccination in four low- and middle-income countries"],"prefix":"10.1016","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9323-6703","authenticated-orcid":false,"given":"Margaret J.","family":"de Villiers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"de Villiers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shevanthi","family":"Nayagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy B.","family":"Hallett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.epidem.2024.100798_b1","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/aje\/kwx037","article-title":"Estimating direct and indirect protective effect of influenza vaccination in the United States","volume":"186","author":"Arinaminpathy","year":"2017","journal-title":"Am. J. Epidemiol."},{"issue":"1","key":"10.1016\/j.epidem.2024.100798_b2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1177\/0272989X02239651","article-title":"Economic evaluation of vaccination programs: the impact of herd-immunity","volume":"23","author":"Brisson","year":"2003","journal-title":"Med. Decis. Mak."},{"issue":"4","key":"10.1016\/j.epidem.2024.100798_b3","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1053\/j.gastro.2011.12.035","article-title":"Effects of maternal screening and universal immunization to prevent mother-to-infant transmission of HBV","volume":"142","author":"Chen","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.epidem.2024.100798_b4","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26475-6","article-title":"The impact of the timely birth-dose vaccine on the global elimination of hepatitis B","volume":"12","author":"de Villiers","year":"2021","journal-title":"Nature Commun."},{"key":"10.1016\/j.epidem.2024.100798_b5","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jval.2015.02.004","article-title":"Public health impact and cost-effectiveness of hepatitis A vaccination in the United States: a disease transmission dynamic modeling approach","volume":"18","author":"Dhankhar","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/j.epidem.2024.100798_b6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1098\/rspb.1993.0102","article-title":"The influence of age on the development of the hepatitis B carrier state","volume":"253","author":"Edmunds","year":"1993","journal-title":"Proc. R. Soc. London B"},{"key":"10.1016\/j.epidem.2024.100798_b7","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0264-410X(02)00623-0","article-title":"The global value of vaccination","volume":"21","author":"Ehreth","year":"2003","journal-title":"Vaccine"},{"issue":"308","key":"10.1016\/j.epidem.2024.100798_b8","article-title":"Direct and indirect effects of influenza vaccination","volume":"17","author":"Eichner","year":"2017","journal-title":"BMC Infect. Dis."},{"issue":"28","key":"10.1016\/j.epidem.2024.100798_b9","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1016\/j.vaccine.2023.05.034","article-title":"Estimating global changes in routine childhood vaccination coverage during the COVID-19 pandemic, 2020\u20132021","volume":"41","author":"Ghaznavi","year":"2023","journal-title":"Vaccine"},{"key":"10.1016\/j.epidem.2024.100798_b10","series-title":"Statistics for Biology and Health","doi-asserted-by":"crossref","DOI":"10.1007\/978-0-387-68636-3_2","article-title":"Design and Analysis of Vaccine Studies","author":"Halloran","year":"2010"},{"issue":"101925","key":"10.1016\/j.epidem.2024.100798_b11","article-title":"Assessment of vaccine herd protection in a cluster-randomised trial of vi conjugate vaccine against typhoid fever: results of further analysis","volume":"58","author":"Khanam","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.epidem.2024.100798_b12","doi-asserted-by":"crossref","first-page":"6550","DOI":"10.1016\/j.vaccine.2009.08.048","article-title":"Epidemiological serosurvey of hepatitis B in China \u2014 declining HBV prevalence due to hepatitis B vaccination","volume":"27","author":"Liang","year":"2009","journal-title":"Vaccine"},{"issue":"12","key":"10.1016\/j.epidem.2024.100798_b13","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S1473-3099(16)30204-3","article-title":"Requirements for global elimination of hepatitis B: a modelling study","volume":"16","author":"Nayagam","year":"2016","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.epidem.2024.100798_b14","doi-asserted-by":"crossref","first-page":"796","DOI":"10.7326\/0003-4819-135-9-200111060-00009","article-title":"Hepatitis B virus infection in children and adolescents in a hyperendemic area: 15 years after mass hepatitis B vaccination","volume":"135","author":"Ni","year":"2001","journal-title":"Ann. Intern. Med."},{"issue":"7","key":"10.1016\/j.epidem.2024.100798_b15","article-title":"Efficacy and effectiveness of infant vaccination against chronic hepatitis B in the Gambia Hepatitis Intervention Study (1986\u201390) and in the nationwide immunisation program","volume":"14","author":"Peto","year":"2014","journal-title":"BMC Infect. Dis."},{"issue":"1","key":"10.1016\/j.epidem.2024.100798_b16","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/ije\/13.1.87","article-title":"Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies","volume":"13","author":"Smith","year":"1984","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.epidem.2024.100798_b17","series-title":"MATLAB version: 9.14.0 (r2023a)","author":"The MathWorks Inc.","year":"2023"},{"issue":"e67635","key":"10.1016\/j.epidem.2024.100798_b18","article-title":"Lives saved with vaccination for 10 pathogens across 112 countries in a pre-COVID-19 world","volume":"10","author":"Toor","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.epidem.2024.100798_b19","series-title":"Case Studies in Public Health","isbn-type":"print","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/B978-0-12-804571-8.00003-2","article-title":"Maurice hilleman: creator of vaccines that changed the world","author":"Tulchinsky","year":"2018","ISBN":"https:\/\/id.crossref.org\/isbn\/9780128045718"},{"key":"10.1016\/j.epidem.2024.100798_b20","series-title":"World population prospects 2019","author":"United Nations, Department of Economic and Social Affairs, Population Division","year":"2019"},{"issue":"138","key":"10.1016\/j.epidem.2024.100798_b21","article-title":"The public health value of vaccines beyond efficacy: methods, measures and outcomes","volume":"15","author":"Wilder-Smith","year":"2017","journal-title":"BMC Med."},{"key":"10.1016\/j.epidem.2024.100798_b22","series-title":"Combating Hepatitis B and C to Reach Elimination by 2030","author":"World Health Organization","year":"2016"},{"issue":"27","key":"10.1016\/j.epidem.2024.100798_b23","first-page":"369","article-title":"Hepatitis B vaccines: WHO position paper \u2014 July 2017","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly. Epidemiol. Rec."},{"issue":"2","key":"10.1016\/j.epidem.2024.100798_b24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.vaccine.2017.07.046","article-title":"Hepatitis B vaccines: WHO position paper, July 2017 \u2014 Recommendations","volume":"37","author":"World Health Organization","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.epidem.2024.100798_b25","series-title":"Immunization coverage","author":"World Health Organization","year":"2023"},{"key":"10.1016\/j.epidem.2024.100798_b26","series-title":"Global Hepatitis Report 2024: Action for Access in Low- and Middle-Income Countries","author":"World Health Organization","year":"2024"},{"key":"10.1016\/j.epidem.2024.100798_b27","series-title":"Hepatitis B","author":"World Health Organization","year":"2024"},{"key":"10.1016\/j.epidem.2024.100798_b28","series-title":"Estimates of national immunisation coverage","author":"World Health Organization (WHO)\/United Nations Children\u2019s Fund (UNICEF)","year":"2021"}],"container-title":["Epidemics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1755436524000598?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1755436524000598?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T19:53:54Z","timestamp":1786218834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1755436524000598"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":28,"alternative-id":["S1755436524000598"],"URL":"https:\/\/doi.org\/10.1016\/j.epidem.2024.100798","relation":{},"ISSN":["1755-4365"],"issn-type":[{"value":"1755-4365","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct and indirect effects of hepatitis B vaccination in four low- and middle-income countries","name":"articletitle","label":"Article Title"},{"value":"Epidemics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.epidem.2024.100798","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100798"}}